BeStock  
Stocks › Biotechnology › INCY

Incyte INCY

US equityMarket cap rank #824BiotechnologyCAR-T Therapy
$114.63 −$1.25 (-1.07%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $114.63 0.00%
Open$116.85
Prev close$115.87
Day range$114.28 – $117.51
Volume1.54M
Market cap$23.36B
P/E (TTM)58.5
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$1.56B+14.0% YoY
Operating profit-$707.45M-264.0% YoY
Net profit-$784.80M-285.0% YoY
Diluted EPS-$3.86-282.9% YoY
Free cash flow-$690.95M-233.0% YoY
Operating cash flow-$675.32M

Revenue, last 8 quarters

$1.2BDec '24$1.1BMar '25$1.2BJun '25$1.4BSep '25$1.5BDec '25$1.3BMar '26$1.7BJun '26$1.6BSep '26

Net profit, last 8 quarters

$201.2MDec '24$158.2MMar '25$405.0MJun '25$424.2MSep '25$299.3MDec '25$303.3MMar '26$585.6MJun '26$-784.8MSep '26

Diluted EPS by quarter

1.02Dec '240.80Mar '252.04Jun '252.11Sep '251.46Dec '251.47Mar '262.81Jun '26-3.86Sep '26

Free cash flow by quarter

$363.8MDec '24$262.9MMar '25$25.7MJun '25$519.6MSep '25$521.4MDec '25$354.2MMar '26$495.2MJun '26$-691.0MSep '26

Annual revenue

$2.7BFY20$3.0BFY21$3.4BFY22$3.7BFY23$4.2BFY24$5.1BFY25

Profitability & balance sheet

Gross margin92.7%
Operating margin11.7%
Net margin6.7%
Return on equity7.8%
Return on assets5.9%
Return on invested capital6.2%
Current ratio3.84
Liabilities / assets22.6%
Cash & investments$3.85B
Total debt$27.63M
Net cash (debt)$3.83B
Free cash flow / sales11.3%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $1.56B $1.67B $1.27B $5.14B $1.51B
Total Operating Revenue $1.56B $1.67B $1.27B $5.14B $1.51B
Cost of Revenue $108.70M $105.00M $104.50M $372.10M $121.10M
Gross Profit $1.45B $1.57B $1.17B $4.77B $1.39B
Operating Expense $2.16B $868.65M $844.00M $3.43B $1.00B
Selling and Admin Expenses $364.30M $351.70M $328.10M $1.38B $390.40M
-General & Admin Expense $364.30M $351.70M $328.10M $1.38B $390.40M
Research & Development $1.79B $516.95M $515.90M $2.05B $611.37M
Operating Profit -$707.45M $700.39M $324.17M $1.34B $383.96M
Net Non-Operating Interest Income (Expense) $31.57M $37.54M $33.12M $103.17M $30.17M
Non-Operating Interest Income $32.17M $38.12M $33.69M $105.60M $30.75M
Non-Operating Interest Expense $605,000.00 $582,000.00 $569,000.00 $2.43M $582,000.00
Other Income (Expense) -$12.95M $13.58M -$13.68M $218.53M -$24.11M
Gain on Sale of Security -$13.23M $9.81M $6.59M $21.31M $18.25M
Special Income (Charges) -$892,000.00 -$2.50M -$23.05M $172.11M -$48.02M
-Less:Restructuring and Mergern & Acquisition $892,000.00 $2.50M -$168,000.00 -$6.13M -$28.26M
-Less:Write Off $0.00 $0.00 $23.21M $76.28M $76.28M
Other Non-Operating Income (Expenses) $1.17M $6.28M $2.77M $25.11M $5.66M
Pretax Profit -$688.85M $751.51M $343.60M $1.66B $389.94M
Tax $95.96M $165.91M $40.27M $377.80M $90.66M
Net Profit -$784.80M $585.61M $303.33M $1.29B $299.28M
Profit from Continuing Operations -$784.80M $585.61M $303.33M $1.29B $299.28M
Net Income to Parent Company -$784.80M $585.61M $303.33M $1.29B $299.28M
Net Income to Common Stockholders -$784.80M $585.61M $303.33M $1.29B $299.28M
Basic EPS -$3.86 $2.92 $1.52 $6.59 $1.52
Diluted EPS -$3.86 $2.81 $1.47 $6.41 $1.46
-Less:Other Special Charges – – – -$242.25M $0.00

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $7.29B $7.87B $7.34B $6.96B $6.96B
Total Current Assets $5.52B $6.03B $5.48B $5.02B $5.02B
Cash and Cash Equivalents & Short-Term Investments $3.85B $4.54B $4.02B $3.58B $3.58B
-Cash and Cash Equivalents $3.28B $3.98B $3.46B $3.10B $3.10B
-Short Term Investments $578.69M $553.37M $554.71M $482.79M $482.79M
Receivables $1.24B $1.13B $1.05B $1.02B $1.02B
-Accounts Receivable $1.24B $1.13B $1.05B $1.02B $1.02B
Inventory $134.25M $112.54M $115.62M $101.06M $101.06M
Other Current Assets $295.52M $253.09M $301.31M $317.83M $317.83M
Total Non-Current Assets $1.77B $1.85B $1.85B $1.93B $1.93B
Net PPE $725.79M $735.03M $746.84M $758.41M $758.41M
-Gross PPE $1.14B $1.14B $1.14B $1.13B $1.13B
-Accumulated Depreciation -$414.71M -$403.91M -$389.00M -$375.07M -$375.07M
Investments and Advances $91.16M $104.39M $54.58M $47.99M $47.99M
-Long Term Equity Investment $91.16M $104.39M $54.58M $47.99M $47.99M
Goodwill and Other Intangible Assets $236.23M $236.20M $243.16M $250.13M $250.13M
-Goodwill $133.00M $133.00M $133.00M $133.00M $133.00M
-Other Intangible Assets $103.23M $103.20M $110.16M $117.13M $117.13M
Non-Current Deferred Assets $281.69M $336.86M $452.52M $515.29M $515.29M
Other Non-Current Assets $431.02M $433.60M $357.75M $362.25M $362.25M
Total Liabilities $1.64B $1.53B $1.72B $1.79B $1.79B
Total Current Liabilities $1.44B $1.31B $1.49B $1.52B $1.52B
Payables $238.25M $252.64M $234.56M $214.69M $214.69M
-Accounts Payable $235.37M $250.40M $228.62M $209.94M $209.94M
-Total Tax Payable $2.88M $2.24M $5.93M $4.76M $4.76M
Current Accrued Expenses $267.21M $267.51M $279.92M $287.86M $287.86M
Short-Term Debt and Capital Lease Obligation $9.78M $9.85M $10.02M $10.21M $10.21M
-Current Capital Lease Obligation $9.78M $9.85M $10.02M $10.21M $10.21M
Current Provisions $623.94M $526.44M $722.41M $642.47M $642.47M
Other Current Liabilities $107.65M $107.35M $117.83M $131.87M $131.87M
Total Non-Current Liabilities $206.50M $216.12M $226.62M $275.33M $275.33M
Long Term Debt and Capital Lease Obligation $27.63M $28.42M $29.41M $30.20M $30.20M
-Long Term Capital Lease Obligation $27.63M $28.42M $29.41M $30.20M $30.20M
Other Non-Current Liabilities $178.87M $187.70M $197.20M $245.13M $245.13M
Total Equity $5.64B $6.34B $5.62B $5.17B $5.17B
Stockholders' Equity $5.64B $6.34B $5.62B $5.17B $5.17B
Capital Stock $204,000.00 $201,000.00 $200,000.00 $198,000.00 $198,000.00
-Common Stock $204,000.00 $201,000.00 $200,000.00 $198,000.00 $198,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $5.31B $5.22B $5.08B $4.93B $4.93B
Retained Earnings $317.90M $1.10B $517.10M $213.77M $213.77M
Gains/Losses Not Affecting Retained Earnings $13.46M $19.72M $22.31M $25.46M $25.46M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$675.32M $507.66M $369.35M $1.41B $543.30M
Net cash flow from continuing operations -$675.32M $507.66M $369.35M $1.41B $543.30M
Net Income from Continuing Operations -$784.80M $585.61M $303.33M $1.29B $299.28M
Gain/Loss from Continuing Operations $13.23M – – -$21.31M -$18.25M
Depreciation & Depletion & Amortization $24.18M $26.48M $23.80M $93.29M $23.98M
Deferred Tax $92.73M $115.62M $63.42M $247.69M $13.50M
Other Non-Cash Items $9.60M $4.11M $12.60M $8.73M -$16.85M
Change in Working Capital -$100.04M -$281.61M -$91.34M -$527.16M $103.20M
-Change in Receivables -$111.87M -$73.80M -$27.03M -$170.77M -$128.50M
-Change in Inventory -$21.67M -$11.88M -$12.23M -$58.51M -$4.86M
-Change in Prepaid Assets -$80.85M -$14.04M $9.19M -$156.24M $65.04M
-Change in Payables and Accrued Expense $114.35M -$181.89M -$61.28M -$141.64M $171.52M
Net cash flow from investing -$44.34M -$51.79M -$88.20M -$102.61M -$37.42M
Net Cash Flow from Continuing Investing Activities -$44.34M -$51.79M -$88.20M -$102.61M -$37.42M
Capital Expenditure -$15.63M -$12.41M -$10.20M -$58.87M -$21.88M
Net Intangibles Purchase and Sale $0.00 $0.00 -$5.00M -$25.00M $0.00
Net Investment Purchase and Sale -$28.70M -$39.38M -$73.00M -$18.74M -$15.54M
Financing Cash Flow $13.94M $65.46M $84.82M $101.04M $137.74M
Net Cash Flow from Continuing Financing Activities $13.94M $65.46M $84.82M $101.04M $137.74M
Net Issuance Payments Of Debt -$1.15M -$1.16M -$1.18M -$4.54M -$1.16M
Proceeds from Stock Option Exercised $122.30M $75.15M $97.93M $221.76M $160.21M
Net Other Financing Charges -$107.22M -$8.53M -$11.92M -$116.18M -$21.31M
Ending Cash Balance $3.28B $3.98B $3.46B $3.10B $3.10B
Net Change in Cash -$705.72M $521.33M $365.97M $1.41B $643.62M
Beginning Cash Balance $3.98B $3.46B $3.10B $1.69B $2.46B
Effect of Exchange Rate Changes -$831,000.00 -$84,000.00 -$2.69M -$1.71M -$801,000.00
Free Cash Flow -$690.95M $495.25M $354.15M $1.33B $521.42M
Net Common Stock Issuance – – – $0.00 $0.00

Discussion

No comments yet — be the first to weigh in on INCY.

Sign in to join the discussion.

Scroll to Top